XML 47 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Revision of Prior Period Financial Statements
9 Months Ended
Jan. 01, 2012
Revision of Prior Period Financial Statements [Abstract]  
Revision of Prior Period Financial Statements
Note 2
Revision of Prior Period Financial Statements

During the third quarter of fiscal 2012, the Company identified errors primarily related to retention bonuses associated with its plan to close its Oregon manufacturing facility ($6.4 million expense).  In addition, the Company had corrected prior period errors in the first and second quarters of 2012 related to retention bonuses ($0.5 million expense) for certain key employees and accounts payable system related issues ($1.0 million benefit) respectively. The Company assessed the materiality of these errors individually and in the aggregate on prior periods' financial statements in accordance with the SEC's Staff Accounting Bulletin No. 99 (“SAB 99”), and concluded that the errors were not material to any of its prior annual or interim financial statements. The Company also concluded that correcting the errors, on a cumulative basis, would not be material to the expected results of operations for the year ended April 1, 2012. However, as permitted in SEC's Staff Accounting Bulletin No. 108 (“SAB 108”), the Company elected to revise previously issued consolidated financial statements the next time they are filed.  As each subsequent filing is made in the future, the previous period consolidated financial statements affected by the errors will be revised. The Company has revised the April 3, 2011 consolidated balance sheet and the consolidated statements of operations for the three and nine months ended January 2, 2011 included herein to reflect the correct balances. Of the above mentioned errors, the amount related to the accounts payable system related issue will be corrected in the opening retained earnings and will not impact the earnings of current or subsequent filings.  The impact of correcting these errors on net income as reported for the interim three month period ended July 3, 2011 and three and six month periods ended October 2, 2011 was a reduction of $1.5 million, $0.8 million and $2.3 million, respectively.
 
Set out below are the line items within the consolidated financial statements as of and for the three and nine months ended January 2, 2011 that have been impacted by the revisions.  The revision had no impact on the Company's total cash flows from operating, investing or financing activities.

   
For the Three Months Ended January 2, 2011
  
For the Nine Months Ended January 2, 2011
 
(in thousands, except per share amounts)
 
As
Reported (1)
  
Adjustments
  
As
 Revised
  
As
Reported (1)
  
Adjustments
  
As
 Revised
 
Consolidated Statement of Operations
                  
Cost of revenues
 $66,507  $670  $67,177  $211,212  $2,010  $213,222 
Gross profit
  81,017   (670)  80,347   249,503   (2,010)  247,493 
Research and development
  40,620   54   40,674   116,612   162   116,774 
Selling, general and administrative
  25,997   20   26,017   77,672   60   77,732 
Total operating expenses
  66,617   74   66,691   194,284   222   194,506 
Operating income
  14,400   (744)  13,656   55,219   (2,232)  52,987 
Income from continuing operations
   before income taxes
  15,752   (744)  15,008   58,012   (2,232)  55,780 
Provision for income taxes
  52   59   111   1,438   221   1,659 
Net income from continuing operations
  15,700   (803)  14,897   56,574   (2,453)  54,121 
Net income
 $10,597  $(803) $9,794  $41,234  $(2,453) $38,781 
                          
Basic income (loss) per share:
                        
    Continuing operations
 $0.10  $-  $0.10  $0.37  $(0.02) $0.35 
    Net income (loss)
 $0.07  $(0.01) $0.06  $0.27  $(0.02) $0.25 
                          
Diluted net income (loss) per share:
                        
    Continuing operations
 $0.10  $-  $0.10  $0.37  $(0.02) $0.35 
    Net income (loss)
 $0.07  $(0.01) $0.06  $0.27  $(0.02) $0.25 
                          
   
As of  April 3, 2011
             
(in thousands)
 
As
Reported
  
Adjustments
  
As
 Revised
             
Consolidated Balance Sheets
                        
Accounts payable
 $36,470  $(1,051) $35,419             
Accrued compensation
    and related expenses
  28,212  $4,572   32,784             
Total current liabilities
  110,645  $3,521   114,166             
Total liabilities
  128,678  $3,521   132,199             
Accumulated deficit
  (837,075)  (3,521)  (840,596)            
Total stockholders' equity
 $598,782  $(3,521) $595,261             
                          
1) Reflect's previously reported amounts as adjusted for discontinued operations (see Note 6).